Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 Apr 2024 10:15–12:10 Zürich Svizzera
Evento S-GE Fattori chiave di successo per fare affari in Giappone 23 Apr 2024 10:15–12:10 Zürich Svizzera
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 Lug 2024–28 Lug 2024 Nangang District Taiwan
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan 23 Apr 2024 10:15–12:10 Zürich Svizzera
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 Lug 2024–28 Lug 2024 Nangang District Taiwan
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 Lug 2024–28 Lug 2024 Nangang District Taiwan
Actualités 17 Apr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Entretiens-Pays Conseil export - Journées spéciales Australie Rencontrez notre experte venue d'Australie! Renens Suisse
News 10 Gen 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 19 Dic 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 10 Mag 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 03 Mag 2024 GEMÜ announces plans to expand Emmen plant GEMÜ has drawn up plans for a comprehensive expansion project at its Emmen plant first opened in 2012. Since this time, the company, which is hea...